Retraction Note to: Delayed recovery of vecuronium neuromuscular block in diabetic patients during sevoflurane anesthesia (CAN J ANESTH, (2005), 52, 5, (467-473), 10.1007/BF03016524);Delayed recovery of vecuronium neuromuscular block in diabetic patients during sevoflurane anesthesia

Canadian Journal of Anesthesia

Volumn 52, Issue 5, 2005, Pages 467-473

  Saitoh, Yuhji ^a   Hattori, Hisashi ^b   Sanbe, Norie ^b   Nakajima, Hiroshi ^b   Akatu, Masahiko ^b   Murakawa, Masahiro ^b  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

^b FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE; DIAZEPAM; FENTANYL; GLIBENCLAMIDE; NEOSTIGMINE; NEUTRAL INSULIN; NITROUS OXIDE PLUS OXYGEN; PROPOFOL; SEVOFLURANE; THIOPENTAL; VECURONIUM;

ADULT; AGED; ANESTHETIC RECOVERY; ARTICLE; BRADYCARDIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DRUG BLOOD LEVEL; FEMALE; HUMAN; HYPERTENSION; HYPOTENSION; INTRAVENOUS ANESTHESIA; MAJOR CLINICAL STUDY; MALE; NEUROMUSCULAR BLOCKING; PATIENT MONITORING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TACHYCARDIA;

EID: 21244496019     PISSN: 0832610X     EISSN: 14968975     Source Type: Journal    
DOI: 10.1007/s12630-022-02252-x     Document Type: Erratum

References (27)

1. Saitoh Y, Kaneda K, Hattori H, Nakajima H, Murakawa M. Monitoring of neuromuscular block after administration of vecuronium in patients with diabetes mellitus. Br J Anaesth 2003; 90: 480-6.
2. Woolf AL, Malins JM. Changes in the intramuscular nerve endings in diabetic neuropathy: a biopsy study. J Pathol Bacteriol 1957; 73: 316-8.
3. Lawrence DG, Locke S. Motor nerve conduction velocity in diabetes. Arch Neurol 1961; 5: 483-9.
4. Skillman TG, Johnson EW, Hamwi GJ, Driskill HJ. Motor nerve conduction velocity in diabetes mellitus. Diabetes 1961; 10: 46-51.
5. Abu-Shakra SR, Cornblath DR, Avila OL, et al. Conduction block in diabetic neuropathy. Muscle & Nerve 1991; 14: 858-62.
6. Lamontagne A, Buchthal F. Electrophysiological studies in diabetic neuropathy. J Neurol Neurosurg Psychiat 1970; 33: 442-52.
7. Van Slyke MA, Ostrov BE. MRI evaluation of diabetic muscle infarction. Magn Reson Imaging 1995; 13: 325-9.
8. Rocca PV, Alloway JA, Nashel DJ. Diabetic muscle infarction. Semin Arthritis Rheum 1993; 22: 280-7.
9. Eady JL, Cobbs KF. Diabetic muscle infarction. J South Orthop Assoc 1997; 6: 250-5.
10. Scully RE, Mark EJ, McNeely WF, McNeely BU. Case records of the Massachusetts General Hospital. N Engl J Med 1987; 316: 1326-35.
11. Saitoh Y, Toyooka H, Amaha K. Recoveries of post-tetanic twitch and train-of-four responses after administration of vecuronium with different inhalation anaesthetics and neuroleptanaesthesia. Br J Anaesth 1993; 70: 402-4.
12. Saitoh Y, Toyooka H, Amaha K. Relationship between post-tetanic twitch and single twitch response after administration of vecuronium. Br J Anaesth 1993; 71: 443-4.
13. Motamed C, Donati F. Sevoflurane and isoflurane, but not propofol, decrease mivacurium requirements over time. Can J Anesth 2002; 49: 907-12.
14. Dragne A, Varin F, Plaud B, Donati F. Rocuronium pharmacokinetic-pharmacodynamic relationship under stable propofol or isoflurane anesthesia. Can J Anesth 2002; 49: 353-60.
15. Woloszczuk-Gebicka B. Mivacurium infusion requirement and spontaneous recovery of neuromuscular transmission in children anaesthetized with nitrous oxide and fentanyl, halothane, isoflurane or sevoflurane. Paediatr Anaesth 2002; 12: 511-8.
16. Bennett PH. Definition, diagnosis, and classification of diabetes mellitus and impaired glucose tolerance. In: Kahn CR, Weir GC (Eds). Joslin's Diabetes Mellitus, 13th ed. Pennsylvania: Lea & Febiger; 1994: 193-200.
17. Gepts E. Pharmacokinetic concepts for TCI anaesthesia. Anaesthesia 1998; 53(Suppl 1): 4-12.
18. Marsh B, White M, Morton N, Kenny GN. Pharmacokinetic model driven infusion of propofol in children. Br J Anaesth 1991; 67: 41-8.
19. Viby-Mogensen J, Enybaek J, Eriksson LI, et al. Good clinical research practice (GCRP) in pharmacodynamic studies of neuromuscular blocking agents. Acta Anaesthesiol Scand 1996; 40: 59-74.
20. Lee GC, Iyengar S, Szenohradszky J, et al. Improving the design of muscle relaxant studies. Stabilization period and tetanic recruitment. Anesthesiology 1997; 86: 48-54.
21. McCoy EP, Mirakhur RK, Connolly TM, Loan PB. The influence of the duration of control stimulation on the onset and recovery of neuromuscular block. Anesth Analg 1995; 80: 364-7.
22. Savarese JJ, Caldwell JE, Lien CA, Miller RD. Pharmacology of muscle relaxants and their antagonists. Miller RD (Ed.). Anesthesia, 5th ed. Philadelphia: Churchill Livingstone; 2000: 471-2.
23. Saitoh Y, Kaneda K, Toyooka H, Amaha K. Post-tetanic count and single twitch height at the onset of reflex movement after administration of vecuronium under different types of anaesthesia. Br J Anaesth 1994; 72: 688-90.
24. Lowry DW, Mirakhur RK, McCarthy GJ, Carroll MT, McCourt KC. Neuromuscular effects of rocuronium during sevoflurane, isoflurane, and intravenous anesthesia. Anesth Analg 1998; 87: 936-40.
25. Wulf H, Kahl M, Ledowski T. Augmentation of the neuromuscular blocking effects of cisatracurium during desflurane, sevoflurane, isoflurane or total i.v. anaesthesia. Br J Anaesth 1998; 80: 308-12.
26. Kopman AF. The relationship of evoked electromyographic and mechanical responses following atracurium in humans. Anesthesiology 1985; 63: 208-11.
27. Motulski H. Choosing an Appropriate Sample Size. Institutive Biostatistics, 1st ed. New York: Oxford University Press; 1995: 195-204.